Evidence map›Paper›PMID 42646402›Full record

ReviewNanomaterials (Basel, Switzerland)2026

Are Silver and Gold Nanoparticles Obtained by 'Green' Synthesis Biocompatible?

Lucas Reijnders

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lucas ReijndersFaculty of Science, Institute for Biodiversity and Ecosystem Dynamics, Science Park 904, 1090GE Amsterdam, The Netherlands.ORCID 0000-0002-2969-0661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In scientific literature, the biosynthesis of gold and silver nanoparticles and synthesis of these nanoparticles using small organic molecules such as citrate have been called 'green' processes. In abstracts of scientific publications, gold or silver nanoparticles obtained by 'green' synthesis have rather frequently been characterized as biocompatible. Biocompatible means having no negative impact on exposed organisms. Two reasons have been used to underpin this characterization. The first is the biocompatibility of the substances used in 'green' synthesis and coating nanoparticles. This reason lacks a solid empirical basis. The second reason given for biocompatibility is limited testing of the nanoparticles obtained by 'green' synthesis (mainly in vitro testing). Such limited testing is inconclusive. Use-specific comprehensive in vitro and in vivo testing, including clinical studies, and control of hazardous substances such as lipopolysaccharide and flagellins are needed to provide a solid basis for their characterization as biocompatible for humans.

Indexed as

biocompatiblebiosynthesisgold nanoparticles‘green’ synthesissilver nanoparticles

Identifiers

PMID42646402
PMCPMC13515772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.